Praxis Precision Medicines Inc (PRAX) — Long-term Investment Intensity

Latest as of December 2025: 34.8%

Praxis Precision Medicines Inc (PRAX) has a Long-term Investment Intensity of 34.8% as of December 2025. Long-term investments of $326.76 Million represent 34.8% of total assets of $937.91 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Praxis Precision Medicines Inc net assets for net asset value and shareholders' equity analysis.

LT Investment Intensity

34.8%
LT Investments / Total Assets

Long-term Investments

$326.76 Million
USD

Total Assets

$937.91 Million
USD

Country

USA
NASDAQ

Praxis Precision Medicines Inc Long-term Investment Intensity (2024–2025)

This chart shows how Praxis Precision Medicines Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the intensity stands at 34.8%, reflecting long-term investments of $326.76 Million against total assets of $937.91 Million USD. Also explore PRAX total asset value for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Praxis Precision Medicines Inc (2024–2025)

The table below presents the year-by-year Long-term Investment Intensity for Praxis Precision Medicines Inc from 2024 to 2025, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Praxis Precision Medicines Inc market capitalisation.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2025 34.8% $326.76 Million $937.91 Million ▲ +18.9 pp
2024 15.9% $76.96 Million $483.11 Million
pp = percentage points